Literature-related discovery: Potential treatments and preventatives for SARS

Abstract Literature-related discovery (LRD) is the linking of two or more previously disjoint concepts in order to produce novel, interesting, plausible, and intelligible connections (i.e., potential discovery). LRD has been used to identify potential treatments or preventative actions for challenging medical problems, among myriad other applications. Severe acute respiratory syndrome (SARS) was the first pandemic of the 21st century. SARS was eventually controlled through increased hygienic measures (e.g., face mask protection, frequent hand washing, living quarter disinfection), travel restrictions, and quarantine. According to recent reviews of SARS, none of the drugs that were used during the pandemic worked. For the present paper, SARS was selected as the first application of LRD to an infectious disease. The main goal of this research was to identify non-drug non-surgical treatments that would 1) prevent the occurrence, or 2) reduce the progression rate, or 3) stop/reverse the progression of SARS. The MeSH taxonomy of Medline was used to restrict potential discoveries to selected semantic classes, and to identify potential discoveries efficiently. To enhance the volume of potential discovery, databases were used in addition to Medline. These included the Science Citation Index (SCI) and, in contrast to previous work, a full text database. Because of the richness of the full text, ‘surgical’ queries were developed that targeted the exact types of potential discovery of interest while eliminating clutter more efficiently.

[1]  P. Fürst,et al.  Nutraceuticals: a piece of history, present status and outlook , 2002 .

[2]  Abhishek S Shah,et al.  Immunomodulatory activity of methanolic extract of Murraya koenigii (L) Spreng. leaves. , 2008, Indian journal of experimental biology.

[3]  Meng-Chen Hsieh,et al.  Effects of fermentation products of Ganoderma lucidum on growth performance and immunocompetence in weanling pigs , 2008, Archives of animal nutrition.

[4]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Methodology , 2008 .

[5]  Young-Seo Park,et al.  Screening of a Natural Feed Additive Having Anti-viral Activity against Influenza A/H5N1 , 2008 .

[6]  K. Hayashi,et al.  Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. , 2008, International immunopharmacology.

[7]  Daniel Janies,et al.  Evolution of genomes, host shifts and the geographic spread of SARS‐CoV and related coronaviruses , 2008, Cladistics : the international journal of the Willi Hennig Society.

[8]  Jingxin Cao,et al.  Aurintricarboxylic Acid Inhibits the Early Stage of Vaccinia Virus Replication byTargeting both Cellular and Viral Factors , 2006, Journal of Virology.

[9]  References , 1971 .

[10]  K. Mochida,et al.  Anti-Influenza Virus Activity of Myrica rubra Leaf Ethanol Extract Evaluated Using Madino-Darby Canine Kidney (MDCK) Cells , 2008, Bioscience, biotechnology, and biochemistry.

[11]  Young-Ok Son,et al.  Stimulating effects on mouse splenocytes of glycoproteins from the herbal medicine Atractylodes macrocephala Koidz. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  D. Hui,et al.  Clinical features, pathogenesis and immunobiology of severe acute respiratory syndrome , 2008, Current opinion in pulmonary medicine.

[13]  Jiang Gu,et al.  Pathology and Pathogenesis of Severe Acute Respiratory Syndrome , 2007, The American Journal of Pathology.

[14]  C. Xiao,et al.  Improvement of the efficacy of influenza vaccination (H5N1) in chicken by using extract of Cochinchina momordica seed (ECMS) , 2007, Journal of Zhejiang University SCIENCE B.

[15]  Yasuhiro Yasutomi,et al.  [Innovation of vaccine adjuvants]. , 2008, Nihon rinsho. Japanese journal of clinical medicine.

[16]  Dirk Thorleuchter,et al.  Mining ideas from textual information , 2010, Expert Syst. Appl..

[17]  Kyo Mochida,et al.  Anti‐influenza virus activity of extract of Japanese wasabi leaves discarded in summer , 2008 .

[18]  C. Perry Clinical Features , 2004, Bristol medico-chirurgical journal.

[19]  Ding-Mei Zhang,et al.  Pathogenesis of severe acute respiratory syndrome. , 2008, Chinese medical journal.

[20]  Peter Schierack,et al.  Bacillus cereus var. toyoi enhanced systemic immune response in piglets. , 2007, Veterinary immunology and immunopathology.

[21]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Potential treatments for Multiple Sclerosis , 2008 .

[22]  Paul Garner,et al.  SARS: Systematic Review of Treatment Effects , 2006, PLoS medicine.

[23]  Maryse M.H. Chappin,et al.  Evaluating innovation networks in emerging technologies , 2011 .

[24]  Zhibin Zhang,et al.  The outbreak pattern of SARS cases in China as revealed by a mathematical model , 2007, Ecological Modelling.

[25]  M. McNutt,et al.  Pathogenetic mechanisms of severe acute respiratory syndrome , 2007, Virus Research.

[26]  Chunfu Wu,et al.  Synergistic immunostimulatory effect of pidotimod and red ginseng acidic polysaccharide on humoral immunity of immunosuppressed mice. , 2008, Die Pharmazie.

[27]  Hyun-Soo Shin,et al.  In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex , 2007, Journal of Clinical Virology.

[28]  Cheng Luo,et al.  Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure–activity relationship studies reveal salient pharmacophore features , 2006, Bioorganic & Medicinal Chemistry.

[29]  Ronald N. Kostoff,et al.  Brief Communication Adjacency and proximity searching in the Science Citation Index and Google , 2006, J. Inf. Sci..

[30]  Po-Huang Liang,et al.  Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3′-digallate (TF3) , 2005, Evidence-based complementary and alternative medicine : eCAM.

[31]  Jing Li,et al.  Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome , 2004, Infection and Immunity.

[32]  Ralph Baric,et al.  SARS coronavirus and innate immunity , 2007, Virus Research.

[33]  Dirk Thorleuchter,et al.  A compared R&D-based and patent-based cross impact analysis for identifying relationships between technologies , 2010 .

[34]  Ronald N Kostoff,et al.  The highly cited SARS research literature , 2010, Critical reviews in microbiology.

[35]  Ali Danesh,et al.  Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome , 2007, Journal of Virology.

[36]  Virginia Korte,et al.  A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. , 2007, Antiviral research.

[37]  Ali Danesh,et al.  Human immunopathogenesis of severe acute respiratory syndrome (SARS) , 2007, Virus Research.

[38]  Yu Song,et al.  Immunopotentiation of Caffeoyl Glycoside from Picrorhiza scrophulariiflora on activation and cytokines secretion of immunocyte in vitro. , 2008, International immunopharmacology.

[39]  Patrick Serrant,et al.  Effect of Lactobacillus paracasei NCC2461 on antigen-specific T-cell mediated immune responses in aged mice. , 2008, Rejuvenation research.

[40]  Makoto Hirano,et al.  Glycosylation‐dependent interaction of Jacalin with CD45 induces T lymphocyte activation and Th1/Th2 cytokine secretion , 2007, Journal of leukocyte biology.

[41]  Ronald N. Kostoff,et al.  Literature-Related Discovery (LRD): Potential treatments for Parkinson's Disease , 2008 .

[42]  Gabriel Vinderola,et al.  Effects of kefir fractions on innate immunity. , 2006, Immunobiology.

[43]  F. Weber,et al.  Interferon and cytokine responses to SARS-coronavirus infection , 2008, Cytokine & Growth Factor Reviews.

[44]  Po-Huang Liang,et al.  Characterization and inhibition of SARS-coronavirus main protease. , 2006, Current topics in medicinal chemistry.

[45]  Scott W. Cunningham,et al.  Innovation forecasting: A case study of the management of engineering and technology literature , 2009, PICMET '09 - 2009 Portland International Conference on Management of Engineering & Technology.

[46]  Chengyu Jiang,et al.  Molecular pathogenesis of severe acute respiratory syndrome , 2006, Microbes and Infection.

[47]  Youjun Feng,et al.  Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus , 2007, Comparative Immunology, Microbiology and Infectious Diseases.

[48]  Tin-Yun Ho,et al.  Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction , 2006, Antiviral Research.

[49]  Ronald N. Kostoff,et al.  Literature-related discovery , 2009, Annu. Rev. Inf. Sci. Technol..

[50]  C. Nakamura,et al.  Antiviral activity and mode of action of a peptide isolated from Sorghum bicolor. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[51]  G. Kuttan,et al.  Modulation of Cell-Mediated Immune Response in B16F-10 Melanoma-Induced Metastatic Tumor-Bearing C57BL/6 Mice by Sulforaphane , 2007, Immunopharmacology and immunotoxicology.

[52]  Pei-Chun Lee,et al.  Quantitative mapping of scientific research—The case of electrical conducting polymer nanocomposite , 2010, Technological Forecasting and Social Change.

[53]  Seong Kyu Song,et al.  Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice. , 2007, Vaccine.

[54]  Y. Lau,et al.  Pathogenesis of severe acute respiratory syndrome , 2005, Current Opinion in Immunology.

[55]  Ranjith,et al.  Enhanced Phagocytosis and Antibody Production by Tinospora cordifolia - A new dimension in Immunomodulation , 2008 .

[56]  Po-Huang Liang,et al.  Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. , 2007, Journal of medicinal chemistry.

[57]  V. Cheng,et al.  Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection , 2007, Clinical Microbiology Reviews.

[58]  Ronald N. Kostoff,et al.  Literature-Related Discovery (LRD): Introduction and background , 2008 .

[59]  Ralph Baric,et al.  Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation , 2008, Microbiology and Molecular Biology Reviews.